|
1) Ayyanathan K, Webbs TE, Sandhu AK, et al. Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun. 1996; 218: 783-8
|
|
|
|
2) Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001; 409: 202-7
|
|
|
|
|
|
3) Offermanns S, Toombs CF, Hu Y, et al. Defective platelet activation in Gαq-deficient mice. Nature. 1997; 389: 183-6
|
|
|
|
|
|
4) Moers A, Wettschureck N, Gruner S, et al. Unresponsiveness of platelets lacking both Gαq and Gα13. Implications for collagen-induced platelet activation. J Biol Chem. 2004; 279: 45354-9
|
|
|
|
|
|
5) Fabre JE, Nguyen M, Latour A, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med. 1999; 5: 1199-202
|
|
|
|
|
|
6) Leon C, Hechler B, Freund M, et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest. 1999; 104: 1731-7
|
|
|
|
|
|
7) Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest. 2001; 107: 1591-8
|
|
|
|
|
|
8) Andre P, Delaney SM, LaRocca T, et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest. 2003; 112: 398-406
|
|
|
|
|
|
9) Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost. 2001; 86: 222-32
|
|
|
|
|
|
10) Nurden P, Savi P, Heilmann E, et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest. 1995; 95: 1612-22
|
|
|
|
|
|
11) Cattaneo M, Lecchi A, Randi AM, et al. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood. 1992; 80: 2787-96
|
|
|
|
|
|
12) Cattaneo M, Lecchi A, Lombardi R, et al. Platelets from a patient heterozygous for the defect of P2cyc receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores. Arterioscler Thromb Vasc Biol. 2000; 20: e101-6
|
|
|
|
|
|
13) Conley P, Jurek M, Vincent D, et al. Unique mutations in the P2Y12 locus of patients with previously described defects in ADP-dependent aggregation [abstract]. Blood. 2001; 98: 43b. Abstract 3778
|
|
|
|
|
|
14) Cattaneo M, Zighetti ML, Lombardi R, et al. Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A. 2003; 100: 1978-83
|
|
|
|
|
|
15) Shiraga M, Miyata S, Kato H, et al. Impaired platelet function in a P2Y12-deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost. 2004; 3: 2315-2
|
|
|
|
|
|
16) Remijn JA, Ijsseldijk MJ, Strunk AL, et al. Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis. Clin Chem Lab Med. 2007; 45: 187-
|
|
|
|
|
|
17) Kim S, Jin J, Kunapuli SP. Akt activation in platelets depends on Gi signaling pathways. J Biol Chem. 2004; 279: 4186-95
|
|
|
|
|
|
18) Shankar H, Murugappan S, Kim S, et al. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood. 2004; 104: 1335-43
|
|
|
|
|
|
19) Zhang W, Colman RW. Thrombin regulates intracellular cAMP concentration in human platelets through phosphorylation/activation of PDE3A. Blood. 2007; prepublished online: DOI 10. 1182/blood- 2006-10- 05252
|
|
|
|
|
|
20) Kamae T, Shiraga M, Kashiwagi H, et al. Critical role of ADP interaction with P2Y12 receptor in the maintenance of αIIbβ3 activation: association with Rap1b activation. J Thromb Haemost. 2005; 4: 1379-87
|
|
|
|
|